Resultados da pesquisa por Autor

1

Development of replication-competent adenovirus based vaccine vectors

Development of replication-competent adenovirus based vaccine vectors

Por Abbink, P, Maxfield, LF, Barouch, DH
Publicado em 2012

Obter o texto integral
Obter o texto integral

Artigo

2

Adenovirus serotype 26 utilizes CD46 as primary cellular receptor and only transiently activates T lymphocytes following vaccination of rhesus monkeys

Adenovirus serotype 26 utilizes CD46 as primary cellular receptor and only transiently activates T lymphocytes following vaccination of rhesus monkeys

Por Li H, Rhee EG, Masek-Hammerman K, Teigler JE, Abbink P, Barouch DH
Publicado em 2012-09-01

Artigo

3

Adenovirus serotype 26 utilizes CD46 as primary cellular receptor and only transiently activates T lymphocytes following vaccination of rhesus monkeys

Adenovirus serotype 26 utilizes CD46 as primary cellular receptor and only transiently activates T lymphocytes following vaccination of rhesus monkeys

Por Li, H, Rhee, EG, Masek-Hammerman, K, Teigler, JE, Abbink, P, Barouch, DH
Publicado em 2012

Obter o texto integral
Obter o texto integral

Artigo

4

Development of a novel simian adenovirus 24 based vaccine vector

Development of a novel simian adenovirus 24 based vaccine vector

Por Abbink, P, Bradley, RR, Ball, F, Ng'ang'a, D, Borducchi, E, Barouch, DH
Publicado em 2012

Obter o texto integral
Obter o texto integral

Artigo

5

OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector

OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector

Por Baden, LR, Dolin, R, O'Brien, KL, Abbink, P, La Porte, A, Seaman, MS, Choi, E, Tucker, R, Weitjens, M, Pau, MG, Goudsmit, J, Barouch, DH
Publicado em 2009

Obter o texto integral
Obter o texto integral

Artigo